If you have any of the conditions below, you may not be the best candidate for a weight loss program like semaglutide: Thyroid cancer Endocrine tumor Kidney disease Eye issues History of pancreatitis GI issues Thyroid cancer If you are pregnant or breastfeeding, you may also not be the right candidate for injections for weight loss
Less DPP-4 activity means more active GLP-1 circulating in the system
Understanding this practical guidance to optimize the therapy, manage potential side effects, and ensure successful incorporation of Tirzepatide into a comprehensive treatment plan
Inspect for Signs of Degradation Before using the medication, look for any signs of cloudiness, discoloration, or particles in the liquid
as a GLP-1-class compound it would be prescription-only in the EU and UK (EMA/MHRA) and requires physician supervision Gastrointestinal effects seen with incretin agonists (nausea, vomiting, diarrhoea) are expected during trials Long-term safety is not yet established outside the clinical-trial setting No dosing is provided here